Medical Article

To celebrate Tom Racobaldo’s upcoming retirement, Compass One Healthcare leaders who have worked closely with Tom over the years were asked to describe his impact on operations, culture and their lives. Their responses show the gratitude, respect and admiration each person has for Tom:  Bobby Kutteh, CEO, Compass One Healthcare   Tom has been the complete leader for our organization. His capability, steadiness, and character are unmatched. He’s a great business leader who always achieved outstanding results, but he did it by…

Through new diagnostic methods, integrated approaches and innovative management solutions, patients no longer have to live with discomfort. Here are three major ways the GI field is evolving to better care for patients today.  The post Thinking with Our Gut: How the Management of GI Conditions is Evolving appeared first on MedCity News.

Despite all the noise around the updates, there’s one area that’s been conspicuously absent this year: enforcement of patient estimate requirements. The post Price Transparency Enforcement Is Still A Shared Responsibility appeared first on MedCity News.

[Sponsored] At INVEST Digital Health 2025, David Snow, Executive Director of Pegasus Park, discussed building a life science innovation hub and why life science startups at the North Texas campus are more likely to survive, scale, and exit. The post The Burgeoning Life Science Ecosystem of North Texas, Anchored by Pegasus Park appeared first on…

September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children’s. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity…

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing;…